Number of the records: 1  

HPMA Copolymer-Bound Doxorubicin Induces Immunogenic Tumor Cell Death

  1. 1.
    0425011 - MBÚ 2014 RIV NL eng J - Journal Article
    Šírová, Milada - Kabešová, Martina - Kovář, Lubomír - Etrych, Tomáš - Strohalm, Jiří - Ulbrich, Karel - Říhová, Blanka
    HPMA Copolymer-Bound Doxorubicin Induces Immunogenic Tumor Cell Death.
    Current Medicinal Chemistry. Roč. 20, č. 38 (2013), s. 4815-4826. ISSN 0929-8673. E-ISSN 1875-533X
    R&D Projects: GA ČR GAP301/12/1254
    Institutional support: RVO:61388971 ; RVO:61389013
    Keywords : Anti-tumor immune response * calreticulin * heat shock proteins
    Subject RIV: CE - Biochemistry
    Impact factor: 3.715, year: 2013

    Treatment of murine EL4 T cell lymphoma with N-(2-hydroxypropyl) methacrylamide (HPMA) copolymer conjugates of doxorubicin (Dox) leads to complete tumor regression and to the development of therapy-dependent long-lasting cancer resistance. This phenomenon occurs with two types of Dox conjugates tested, despite differences in the covalent linkage of Dox to the polymer carrier. Such a cancer resistance cannot fully express in conventional treatment with free Dox, due to substantial immunotoxicity of the treatment, which was not observed in the polymer conjugates. In this study, calreticulin (CRT) translocation and high mobility group box-1 protein (HMGB1) release was observed in EL4 cells treated with a conjugate releasing Dox by a pH-dependent manner. As a result, the treated tumor cells were engulfed by dendritic cells (DC) in vitro, and induced their expression of CD80, CD86, and MHC II maturation markers. Conjugates with Dox bound via an amide bond only increased translocation of HSPs to the membrane, which led to an elevated phagocytosis but was not sufficient to induce increase of the maturation markers on DCs in vitro. Both types of conjugates induced engulfment of the target tumor cells in vivo, that was more intense than that seen with free Dox. It means that the induction of anti-tumor immunity documented upon treatment of EL4 lymphoma with HPMA-bound Dox conjugates does not rely solely on CRT-mediated cell death, but involves multiple mechanisms
    Permanent Link: http://hdl.handle.net/11104/0230969

     
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.